[144] Axon Enterprise, Inc. SEC Filing
Axon Enterprise, Inc. (AXON) filed a Form 144 notifying a proposed sale of 100 shares of common stock through Morgan Stanley Smith Barney LLC, with an approximate aggregate market value of $75,254.34. The filing lists 78,504,440 shares outstanding for the issuer and an approximate sale date of 09/11/2025 on NASDAQ. The shares were acquired on 05/13/2024 as restricted stock vesting under a registered plan and payment was recorded on the same date. The filer reported no securities sold in the past three months and included the standard Rule 144 representation regarding absence of undisclosed material adverse information.
- None.
- None.
Insights
TL;DR: Small insider sale disclosed; acquisition came from restricted stock vesting, no recent sales reported.
The filing documents a proposed sale of 100 shares valued at $75,254.34 to be executed through Morgan Stanley Smith Barney on NASDAQ. The shares were obtained via restricted stock vesting under a registered plan on 05/13/2024 with payment noted the same day. The filer indicates no related sales in the prior three months. From a trading-impact perspective, this disclosure is routine and limited in scale based on the absolute number of shares reported.
TL;DR: Filing complies with Rule 144 disclosure for an insider sale tied to vested equity; includes required certifications.
The notice includes required information about the acquisition source (restricted stock vesting), broker details, and the signers representation that no undisclosed material adverse information exists. The form follows standard Rule 144 procedures and contains the customary warning about intentional misstatements. No governance red flags or additional disclosures are present in the filing text provided.